Attenuation of cardiac vascular rhexis: A promising therapeutic target

Coronary Artery Disease

Volumn 24, Issue 3, 2013, Pages 245-252

  Tarikuz Zaman, A K M ^a   Spees, Jeffrey L ^a   Sobel, Burton E ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

ischemia and reperfusion; myocardial infarction; no reflow; vascular rhexis

Indexed keywords

ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; CREATINE KINASE; FLUORESCEIN ISOTHIOCYANATE; ISOTHIOCYANIC ACID; LYSOPHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BLOOD VESSEL FUNCTION; CAPILLARY ENDOTHELIUM; CELL DEATH; COLLATERAL CIRCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; ERYTHROCYTE; EXTRAVASATION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HOMOGENATE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RHEXIS; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ACTINS; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CAPILLARY PERMEABILITY; CELL DEATH; CORONARY OCCLUSION; CORONARY VESSELS; CREATINE KINASE; DISEASE MODELS, ANIMAL; FLUORESCEIN-5-ISOTHIOCYANATE; HEART VENTRICLES; IMMUNOCHEMISTRY; MYOCARDIAL REPERFUSION INJURY; NO-REFLOW PHENOMENON; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN; SMOOTH MUSCLE MYOSINS; TIME FACTORS; VENTRICULAR REMODELING;

EID: 84876413779     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32835d6688     Document Type: Article

References (29)

1. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361:13-20. (Pubitemid 36050955)
2. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 1993; 87:755-763. (Pubitemid 23070806)
3. Chareonthaitawee P, Christian TF, Hirose K, Gibbons RJ, Rumberger JA. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J Am Coll Cardiol 1995; 25:567-573.
4. Jeremy RW, Hackworthy RA, Bautovich G, Hutton BF, Harris PJ. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. J Am Coll Cardiol 1987; 9:989-995. (Pubitemid 17065754)
5. Hellermann JP, Goraya TY, Jacobsen SJ,Weston SA, Reeder GS, Gersh BJ, et al. Incidence of heart failure after myocardial infarction: is it changing over time? Am J Epidemiol 2003; 157:1101-1107. (Pubitemid 36686701)
6. Dargie H. Heart failure post-myocardial infarction: a review of the issues. Heart 2005; 91 (Suppl 2):ii3-ii6, discussion ii31, ii43-38. (Pubitemid 40559325)
7. Velagaleti RS, Pencina MJ, Murabito JM,Wang TJ, Parikh NI, D'Agostino RB, et al. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 2008; 118:2057-2062.
8. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81:1161-1172. (Pubitemid 20119612)
9. Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress. Circulation 2000; 102:IV14-IV23.
10. Gogo P, Dauerman HL, Sobel BE. Reperfusion therapies for acute ST segment elevation myocardial infarction. In: Jeremias A, Brown D, editors. Cardiac intensive care. 2nd ed. Philadelphia: Elsevier; 2010. pp. 110-144.
11. Kloner RA, Ganote CE, Jennings RB. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974; 54:1496-1508.
12. Eeckhout E, Kern MJ. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur Heart J 2001; 22:729-739. (Pubitemid 32625230)
13. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009; 54:281-292.
14. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002; 105:656-662. (Pubitemid 34123444)
15. French CJ, Zaman AK, Kelm RJ Jr, Spees JL, Sobel BE. Vascular rhexis: loss of integrity of coronary vasculature in mice subjected to myocardial infarction. Exp Biol Med 2010; 235:966-973.
16. Zaman AK, French CJ, Spees JL, Binbrek AS, Sobel BE. Vascular rhexis in mice subjected to non-sustained myocardial ischemia and its therapeutic implications. Exp Biol Med 2011; 236:598-603.
17. Corr PB, Saffitz JE, Sobel BE. Lysophospholipids long chain acylcarnitines, and membrane dysfunction in the ischemic heart. In: Stam H, van der Vusse GJ, editors. Lipid metabolism in the normoxic and ischaemic heart. New York: Springer-Verlag; 1987. pp. 199-208. (Pubitemid 17114095)
18. Corr PB, Sobel BE. Arrhythmogenic properties of phospholipid metabolites associated with myocardial ischemia. Fed Proc 1983; 42: 2454-2459. (Pubitemid 13043667)
19. French CJ, Spees JL, Zaman AK, Taatjes DJ, Sobel BE. The magnitude and temporal dependence of apoptosis early after myocardial ischemia with or without reperfusion. FASEB J 2009; 23:1177-1185.
20. Fernandez B, Duran AC, Fernandez MC, Fernandez-Gallego T, Icardo JM, Sans-Coma V. The coronary arteries of the C57BL/6 mouse strains: implications for comparison with mutant models. J Anat 2008; 212:12-18.
21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
22. Fluorescent Microsphere Resource Center. Manual for using fluorescent microspheres to measure regional organ perfusion. Seattle: University of Washington, Division of Pulmonary and Critical Care Medicine. Available at: http://fmrc.pulmcc.washington.edu/documents/fmrcman99.pdf [Accessed 28 June 2012].
23. Gervais M, Demolis P, Domergue V, Lesage M, Richer C, Giudicelli JF. Systemic and regional hemodynamics assessment in rats with fluorescent microspheres. J Cardiovasc Pharmacol 1999; 33:425-432. (Pubitemid 29101987)
24. Buckberg GD, Luck JC, Payne DB, Hoffman JI, Archie JP, Fixler DE. Some sources of error in measuring regional blood flow with radioactive microspheres. J Appl Physiol 1971; 31:598-604.
25. Deveci D, Egginton S. Development of the fluorescent microsphere technique for quantifying regional blood flow in small mammals. Exp Physiol 1999; 84:615-630. (Pubitemid 29401720)
26. Zaman AK, Fujii S, Schneider DJ, Taatjes DJ, Lijnen HR, Sobel BE. Deleterious effects of lack of cardiac PAI-1 after coronary occlusion in mice and their pathophysiologic determinants. Histochem Cell Biol 2007; 128:135-145. (Pubitemid 47197925)
27. Zaman AK, French CJ, Schneider DJ, Sobel BE. A profibrotic effect of plasminogen activator inhibitor type-1 (PAI-1) in the heart. Exp Biol Med 2009; 234:246-254.
28. Sobel BE, Kjekshus JK, Roberts R. Enzymatic estimation of infarct size. In: Hearse DJ, DeLeiris J, editors. Enzymes in cardiology: diagnosis and research. Chichester: John Wiley and Sons Limited; 1979. pp. 257-289.
29. Sobel BE. Biomarkers, surrogates, and evaluation of therapeutic agents: a proposed solution. Coron Artery Dis 1999; 10:339-341. (Pubitemid 29348963)